Oligonucleotide Therapy Market Scope, Industry Key Drivers And Segmentation Report 2023

Spread the love

Year End Offer By The Business Research Company – Get 33% Discount On Opportunities And Strategies Reports And 25% Discount On Global Market Reports

The Oligonucleotide Therapy Global Market Report 2023 by The Business Research Company, provides oligonucleotide therapy market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa for the 27 major global industries. The report covers a ten-year historic period – 2010-2021, and a ten-year forecast period – 2023-2032.

Learn More On The Oligonucleotide Therapy Market:

https://www.thebusinessresearchcompany.com/report/oligonucleotides-therapy-global-market-report

As per The Business Research Company’s comprehensive Oligonucleotide Therapy Global Market Report for 2023, the landscape of the global oligonucleotide therapy market exhibits a commendable expansion, surging from $1.1 billion in 2022 to a noteworthy $1.23 billion in 2023, reflecting an appreciable Compound Annual Growth Rate (CAGR) of 12.2%. However, the geopolitical turbulence induced by the Russia-Ukraine conflict introduces complexities to the global economic recovery post the COVID-19 pandemic, particularly in the short term. The repercussions, including economic sanctions, escalated commodity prices, and supply chain disruptions, precipitate inflationary pressures across goods and services, exerting widespread influence on various global markets. Forecasts paint a compelling future for the global oligonucleotide therapy market, envisioning a substantial augmentation to $2.1 billion by 2027, propelled by a robust CAGR of 14.2%.

One pivotal catalyst steering this transformative trajectory is the burgeoning prevalence of cancer cases worldwide. This surge in cancer incidences emerges as a pivotal driver, poised to significantly contribute to the burgeoning growth of the oligonucleotide therapy market throughout the forecast period. As the global healthcare landscape grapples with the escalating challenges posed by cancer, the imperative for innovative therapeutic solutions, such as oligonucleotide therapy, is underscored, presenting an intricate interplay between market dynamics and the evolving healthcare paradigm.

Get A Free Sample Of The Report (Includes Graphs And Tables):

https://www.thebusinessresearchcompany.com/sample.aspx?id=3398&type=smp

The oligonucleotide therapy market is segmented:

1) By Type: Antisense Oligonucleotide, Aptamer, Other Types

2) By Application: Infectious Diseases, Oncology, Neurodegenerative Disorders, Cardiovascular Diseases, Kidney Diseases, Other End-User

3) By End User: Hospitals, Research Institutes

The developers and providers of the oligonucleotide therapy market are investing in research and development to remodel the design of therapy to reduce its side effects on patients. The new and innovative oligonucleotides allow for precision medicine approaches and can be designed to selectively target any gene with minimal side effects. It also helps in targeting patient-specific sequences that are causative of rare diseases. In August 2020, the FDA granted accelerated approval to Viltepso (viltolarsen) injection, an antisense oligonucleotide for the treatment of Duchenne muscular dystrophy (DMD), which is a genetic disorder, with reduced side effects.

The oligonucleotide therapy market report table of contents includes:

1. Executive Summary

2. Oligonucleotide Therapy Market Characteristics

3. Oligonucleotide Therapy Market Trends And Strategies

4. Oligonucleotide Therapy Market – Macro Economic Scenario

5. Oligonucleotide Therapy Market Size And Growth

…

28. Oligonucleotide Therapy Pipeline Analysis

29. Key Mergers And Acquisitions In The Oligonucleotide Therapy Market

30. Oligonucleotide Therapy Market Future Outlook and Potential Analysis

31. Appendix

Contact Us: